Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan: Epidemiology of Idiopathic Inflammatory Myopathies, Muscle & Nerve. mai, vol.45, issue.5, pp.676-83, 2012. ,
Polymyositis and Dermatomyositis, New England Journal of Medicine. 13 févr, vol.292, issue.7, pp.344-351, 1975. ,
Advances in serological diagnostics of inflammatory myopathies, Curr Opin Neurol, vol.29, issue.5, pp.662-73, 2016. ,
Current Classification and Management of Inflammatory Myopathies, Journal of Neuromuscular Diseases. 29 mai, vol.5, issue.2, pp.109-138, 2018. ,
New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter, Current Rheumatology Reports, vol.20, issue.4, 2018. ,
A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore), vol.70, pp.360-74, 1991. ,
Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients, Medicine (Baltimore). juill, vol.84, issue.4, pp.231-280, 2005. ,
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open, vol.3, p.507, 2017. ,
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies, JAMA Neurology, issue.10, 2018. ,
,
119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, Neuromuscular Disorders. mai, vol.14, issue.5, pp.337-382, 2003. ,
EMC -Traité Médecine AKOS, vol.6, pp.1-11, 2011. ,
Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody, Seminars in Arthritis and Rheumatism. juin, vol.41, issue.6, pp.890-899, 2012. ,
Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. Current Opinion in Rheumatology, vol.26, pp.684-693, 2014. ,
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients, Lupus. juill, vol.14, issue.7, pp.534-576, 2005. ,
Clinical cardiac involvement in idiopathic inflammatory myopathies: A systematic review, International Journal of Cardiology. mai, vol.148, issue.3, pp.261-70, 2011. ,
Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA, The Journal of Rheumatology. 1 déc, vol.36, issue.12, pp.2704-2714, 2009. ,
Malignancy and myositis: novel autoantibodies and new insights: Current Opinion in Rheumatology, vol.22, pp.627-659, 2010. ,
Malignancy in Myositis, Current Rheumatology Reports. juin, vol.13, issue.3, pp.208-223, 2011. ,
DOI : 10.1007/s11926-011-0169-7
Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis, New England Journal of Medicine. 6 févr, vol.314, issue.6, pp.329-363, 1986. ,
Recent advances in dermatomyositis-specific autoantibodies: Current Opinion in Rheumatology, vol.28, pp.636-680, 2016. ,
Integrated classification of inflammatory myopathies, Neuropathology and Applied Neurobiology. févr, vol.43, issue.1, pp.62-81, 2017. ,
AntiMelanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum: Clinical Features of Anti-MDA-5-Positive Patients, Arthritis Care & Research. août, vol.65, issue.8, pp.1307-1322, 2013. ,
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology. 1 janv, vol.46, issue.1, pp.25-33, 2007. ,
Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis, Arthritis & Rheumatism. juin, vol.60, issue.6, pp.1807-1821, 2009. ,
Inflammatory Myopathies With Anti-Ku Antibodies: A Prognosis Dependent on Associated Lung Disease, Medicine. mars, vol.91, issue.2, pp.95-102, 2012. ,
Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome, PLoS ONE, vol.8, issue.4, p.60442, 2013. ,
The clinical phenotype associated with myositis-specific and associated autoantibodies: A metaanalysis revisiting the so-called antisynthetase syndrome, Autoimmunity Reviews. sept, vol.13, issue.9, pp.883-91, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02046821
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes, Q J Med. oct, vol.77, issue.282, pp.1019-1057, 1990. ,
Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1, Brain. sept, vol.139, issue.9, pp.50-50, 2016. ,
Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis, Brain. sept, vol.138, pp.2485-92, 2015. ,
Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity, Autoimmunity Reviews. déc, vol.12, issue.2, pp.210-217, 2012. ,
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients, Annals of the Rheumatic Diseases. janv, vol.73, issue.1, pp.227-259, 2014. ,
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin, Medicine. mai, vol.93, issue.3, pp.150-157, 2014. ,
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody, Brain. août, vol.139, issue.8, pp.2131-2136, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01409979
Polymyositis: an overdiagnosed entity, Neurology. 12 août, vol.61, issue.3, pp.316-337, 2003. ,
Unicorns, dragons, polymyositis, and other mythological beasts, Neurology. 12 août, vol.61, issue.3, pp.288-297, 2003. ,
,
, Rev Med Interne. sept, vol.28, issue.9, pp.603-615, 2007.
Longterm observational study of sporadic inclusion body myositis, Brain, vol.134, issue.11, pp.3176-84, 2011. ,
, 188th ENMC International Workshop: Inclusion Body Myositis, vol.23, pp.1044-55, 2011.
Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement, Neurosurgery & Psychiatry. avr, vol.87, issue.4, pp.373-381, 2016. ,
Capillaroscopie périunguéale : une évaluation simple et fiable de toute pathologie de la microcirculation. La Revue de Médecine Interne, sept, vol.36, issue.9, pp.603-615, 2015. ,
, Collège des enseignants de médecine vasculaire (France), 2013.
, Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis. Swiss Medical Weekly [Internet]. 30 sept, p.147, 2017.
Sclérodermie systémique, EMC -AKOS (Traité de Médecine), vol.11, issue.1, pp.1-10, 2016. ,
Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc. Arthritis & Rheumatism, vol.65, pp.2737-2784, 2013. ,
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J Rheumatol. janv, vol.27, issue.1, pp.155-60, 2000. ,
The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: A critical review, Autoimmunity Reviews. août, vol.16, issue.8, pp.787-95, 2017. ,
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Annals of the Rheumatic Diseases, vol.71, pp.1636-1645, 2012. ,
Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity, Rheumatology. 27 août, vol.46, issue.10, pp.1566-1575, 2007. ,
Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvascular Research, vol.89, pp.122-130, 2013. ,
Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment, J Rheumatol. déc, vol.10, issue.6, pp.930-938, 1983. ,
Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon, J Rheumatol. avr, vol.9, issue.2, pp.289-91, 1982. ,
Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease, Clin Exp Rheumatol. sept, vol.1, issue.3, pp.195-205, 1983. ,
The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases, Best Pract Res Clin Rheumatol. déc, vol.21, issue.6, pp.1093-108, 2007. ,
Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly/dermatomyositis, Scandinavian Journal of Rheumatology. janv, vol.37, issue.1, pp.23-32, 2008. ,
State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis, Seminars in Arthritis and Rheumatism. déc, vol.47, issue.3, pp.432-476, 2017. ,
Patterns of finger capillary abnormalities in connective tissue disease by « wide-field » microscopy. Arthritis Rheum, vol.16, pp.619-647, 1973. ,
Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis, Am J Med. déc, vol.61, issue.6, pp.862-70, 1976. ,
Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis, J Rheumatol. mai, vol.34, issue.5, pp.1012-1020, 2007. ,
Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy, Rheumatology (Oxford). sept, vol.49, issue.9, pp.1699-705, 2010. ,
Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies, Rheumatology (Oxford). 28 août, 2018. ,
Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int, vol.32, pp.3039-3084, 2012. ,
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern, The Journal of Rheumatology. 1 août, vol.43, issue.8, pp.1575-80, 2016. ,
The handheld dermatoscope as a nail-fold capillaroscopic instrument, Arch Dermatol. août, vol.139, issue.8, pp.1027-1057, 2003. ,
Different microvascular involvement in dermatomyositis and systemic sclerosis. A preliminary study by a tight videocapillaroscopic assessment, Clin Exp Rheumatol. avr, vol.30, issue.2, pp.67-70, 2012. ,
Nailfold capillaroscopic changes in dermatomyositis and polymyositis, Clinical Rheumatology. févr, vol.34, issue.2, pp.279-84, 2015. ,
State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis, Seminars in Arthritis and Rheumatism. déc, vol.47, issue.3, pp.432-476, 2017. ,
Nailfold Capillary Microscopy in Adults with Inflammatory Myopathy, Seminars in Arthritis and Rheumatism. avr, vol.39, issue.5, pp.398-404, 2010. ,